Kellett Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$862K Buy
3,424
+94
+3% +$20.2K 0.4% 33
2026
Q1
$724K Buy
3,330
+143
+4% +$31.7K 0.39% 35
2025
Q4
$728K Buy
3,187
+61
+2% +$13.9K 0.42% 35
2025
Q3
$724K Sell
3,126
-142
-4% -$28.9K 0.44% 30
2025
Q2
$607K Sell
3,268
-667
-17% -$124K 0.4% 35
2025
Q1
$824K Buy
3,935
+172
+5% +$33.4K 0.57% 27
2024
Q4
$669K Sell
3,763
-364
-9% -$66.9K 0.46% 29
2024
Q3
$815K Buy
4,127
+100
+2% +$18.7K 0.58% 23
2024
Q2
$691K Sell
4,027
-200
-5% -$33.1K 0.56% 25
2024
Q1
$770K Buy
4,227
+50
+1% +$8.62K 0.53% 32
2023
Q4
$647K Hold
4,177
0.48% 33
2023
Q3
$623K Buy
4,177
+150
+4% +$22K 0.53% 25
2023
Q2
$543K Buy
4,027
+477
+13% +$69.9K 0.49% 27
2023
Q1
$566K Buy
3,550
+100
+3% +$15.3K 0.54% 23
2022
Q4
$558K Hold
3,450
0.54% 22
2022
Q3
$505K Hold
3,450
0.62% 22
2022
Q2
$529K Buy
3,450
+350
+11% +$53.5K 0.68% 22
2022
Q1
$503K Buy
3,100
+480
+18% +$69.7K 0.4% 28
2021
Q4
$354K Buy
+2,620
New +$309K 0.27% 36

Other funds holding ABBV

Kellett Wealth Advisors's ABBV Position: Q2 2026 in Review

Kellett Wealth Advisors increased its AbbVie (ABBV) stake by 2.8% in Q2 2026, buying an estimated $20.2K and bringing the position to 3,424 shares worth $862K. The position accounts for 0.4% of the portfolio, ranked #33.

Kellett Wealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kellett Wealth Advisors held 3,424 shares of AbbVie worth $862K as of Q2 2026.
  • Kellett Wealth Advisors bought 94 AbbVie shares in Q2 2026, an estimated $20.2K.
  • AbbVie made up 0.4% of Kellett Wealth Advisors's portfolio in Q2 2026, its #33 holding.
  • Kellett Wealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kellett Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.